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Abstract
Background: In Dutch laboratories molecular detection of B. pertussis and B. parapertussis is commonly based on
insertion sequences IS481 and IS1001, respectively. Both IS elements are more widely spread among Bordetella species.
Both Bordetella holmesii,a n dB. bronchiseptica can harbour IS481. Also, IS1001 is found among B. bronchiseptica. IS481,
and IS1001 based PCR thus lacks specificity when used for detection of specific Bordetella spp.
Findings: We designed a PCR based on IS1002, another IS element that is present among Bordetella species, and
exploited it as a template in combination with PCR for IS481, and IS1001. In combining the PCRs for IS481, IS1001,
and IS1002, and including an inhibition control, we were able to detect and discriminate all clinically relevant
Bordetella species.
Conclusions: We developed an improved PCR method for specific detection of B. pertussis, B. parapertussis,
B. holmesii, and B. bronchiseptica.
Background
The genus Bordetella is comprised of 8 species, 4 of which
are known to infect humans; B. pertussis, B. parapertussis,
B. holmesii, and B. bronchiseptica. The most important
cause for whooping cough is B. pertussis,f o l l o w e db y
B. parapertussis. Bordetella holmesii was first described in
1995 [1], and has since been isolated from patients with a
serious underlying disease [2-5]. B. bronchiseptica is
usually restricted to animals but occasionally is isolated
from immunocompromised patients [6,7].
A large number of PCR (polymerase chain reaction)
assays have been described for detection of Bordetella
pertussis and B. parapertussis, and more recently B. hol-
mesii [8-14]. Most PCRs are based on detection of the
insertion sequence elements IS481, and IS1001, because
they exist in multiple copies in the chromosome. A high
copy number of PCR target, contributes to the sensitiv-
ity of detection. IS481 (1053 bp) shows a high degree of
homology between different members of Bordetella spe-
cies of 96%. All IS1001 (1306 bp) sequences known in
Genbank are 100% homologues, as is IS1002 (1040 bp).
The degree of homology between IS481, IS1001, and
IS1002 is less than 5%.
The insertion sequences (IS) that are present in Borde-
tella spp., are distributed according to species and/or
host specificity. For example, IS1001 is found in all
B. parapertussis,b u tIS1002 is found only in B. paraper-
tussis that infect humans and is absent from B. parapertus-
sis sheep isolates [15]. B. pertussis harbors both IS481 and
IS1002 while some B. bronchiseptica strains may have
either IS481 or IS1001 [15]. B. holmesii only has IS481.
Due to the distribution of IS481, and IS1001, PCRs for
B. pertussis and B. parapertussis lack specificity [16]. In
recent years many newly developed PCRs were intro-
duced with improved specificity but often with a com-
promise to sensitivity [11,13,14].
The aim of this study was to improve the specificity of
PCR by including another IS element, IS1002, as target
in PCR. IS1002, in addition to IS481, and IS1001, which
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B. parapertussis, and B. bronchiseptica.
Methods
IS1002 has not been exploited before as a template in
PCR detection. We developed a specific IS1002 PCR
(Table 1) to improve our ability to recognize the correct
Bordetella species, and to combine it with IS481, and
IS1001 specific PCRs. Addition of Phocine Herpes Virus
(PhHV) as internal control acts to monitor the extrac-
tion as well as the efficiency of amplification [17].
We investigated standard laboratory strains of Borde-
tella (kindly provided by Dr. Frits Mooi and Kees Heu-
velman, Laboratory for Vaccine Preventable Diseases,
National Institute of Public Health and the Environ-
ment, Bilthoven, The Netherlands), which are shown in
Table 2. Since detection of B. pertussis is of highest con-
cern, we investigated the performance of the newly
developed PCR on 100 clinical samples that were pre-
viously positive. To verify the specificity of the PCR we
investigated 20 clinical respiratory tract samples that
were suspect for other pathogens than Bordetella.P r i o r
to PCR, laboratory strains were diluted and boiled to
release DNA (equivalent to approximately 5 cells/μl).
Clinical samples were extracted using EasyMAG (Bio-
merieux, Grenoble, France).
PCRs for detection of IS481, IS1001, and IS1002 were
performed in a reaction mixture of 25 μlc o n t a i n i n g0 . 5
μMo fIS481 and IS1001 primers, 0.8 μM and 0.6 μMo f
IS1002 Forward and Reverse primer, respectively, and
0.2 μM of PhHV primers. Probes (Table 1) were added
with concentrations of 0.14, 0.14, 0.16, and 0.08 μMf o r
respectively IS481, IS1001, IS1002, and the internal con-
trol in PCR reaction mix (Sigma -Aldrich (E3004),
Munich, Germany). Nine μlo ft e m p l a t eD N Aw a s
added. Amplification was carried out on an ABI 7500
Real-Time PCR system (Applied Biosystems (ABI), Nieu-
werkerk a/d IJsel, The Netherlands). The temperature
profile included initial denaturation of 4 min. at 94°C,
followed by 50 cycles of 94°C for 15 sec., and 60°C for
1 min. Cycle treshold (Ct) values were determined auto-
matically using the ABI SDS software.
Results
Evaluation of sensitivity
In order to evaluate the performance of the combination
of all four PCRs in a multiplex format performed on
standard laboratory strains (Table 2): IS481, IS1001,
IS1002, and the internal control, we compared Ct values
to each single PCR. No significant differences were
found (not shown). Since IS481 is present with a much
higher copy number in B. pertussis than IS1002
(approximately 200 and 10 copies, respectively), Ct
values of IS481 were on average 3.7 lower compared to
Ct values of IS1002 detection. Of a 10 CFU/ml dilution
of B. pertussis cells both IS481 and IS1002 were positive
with Ct values of respectively 30.6 and 34.4. The sensi-
tivity of B. parapertussis detection was comparable with
that using only IS1001 as target.
Evaluation of specificity
To evaluate the specificity of each IS-based PCR, labora-
tory strains of most known Bordetella species (with
exception of B. avium and B. trematum;T a b l e2 ) ,w e r e
subjected to the IS-based PCRs. Results were as was
expected (Table 2).
To investigate whether all targets were amplified with
high fidelity, and would not confound the specificity of
detection, we made serial dilutions and subjected these
to PCR. With limiting concentrations of B. pertussis
bacteria, detection of IS1002 is lost before detection
of IS481, because of the difference in copy number.
Table 1 DNA sequences of primers and probes directed
against three IS elements and the internal control
Phocine Herpes Virus (PhHV)
Template Primer/probe
(label)
Sequence (5’-3’)
IS481 Forward primer GCCGGATGAACACCCATAAG
Reverse primer GCGATCAATTGCTGGACCAT
Probe (FAM) CGATTGACCTTCCTACGTC-MGB
IS1001 Forward primer AATTGCTGCAAGCCAACCA
Reverse primer CCAGAGCCGTTTGAGTTCGT
Probe (VIC) ACATAGACCGTCAGCAG-MGB
IS1002 Forward primer CTAGGTCGAGCCCTTCTTGTTAAC
Reverse primer GCGGGCAAGCCACTTGTA
Probe (CY5) CATCGTCCAGTTCTGTTGCATCACCC-
BBQ
PhHV Forward primer GGGCGAATCACAGATTGAATC
Reverse primer GCGGTTCCAAACGTACCAA
Probe (NED) TTTTTATGTGTCCGCCACCA-MGB
Table 2 Results of PCRs for detection of IS481, IS1001,
and IS1002, and the interpretation for identification of
clinically relevant Bordetella species
Bordetella
subspecies*
IS481 IS1001 IS1002 identification
pertussis + - + B. pertussis
parapertussis - ++ B. parapertussis
holmesii + -- B. holmesii/B.
bronchiseptica
bronchiseptica - + - B. bronchiseptica
petrii - - - identification not
possible
hinzii - - - identification not
possible
*Strains were kindly provided by Dr. Frits Mooi and Kees Heuvelman,
Laboratory for Vaccine Preventable Diseases, National Institute of Public
Health and the Environment, Bilthoven, The Netherlands.
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B. pertussis, 100 previously positive clinical samples
were subjected to PCR. Only when Ct values of IS481
>37, IS1002 was negative (2% of 100 samples). Thus, a
c u t - o f fo fC t3 5s h o u l db et a k e nf o rIS481. In 20
respiratory tract samples suspect for other pathogens,
no Bordetella positives were found. With B. parapertus-
sis PCR detection, similar Ct values of IS1001 and
IS1002 were found, and hence no cut-off Ct values are
necessary for IS1001, and IS1002.
Quality assessment
In addition, the multiplex IS-based PCR was evaluated
using the External Quality Assessment Programme of
Bordetella pertussis from the Quality Control for Mole-
cular Diagnostics (QCMD, Glasgow, UK). The QCMD
panel of samples consisted of 5 B. pertussis in a range
of concentrations, 1 B. parapertussis,1B. holmesii,2B.
bronchiseptica,1B. hinzii,1Haemophilus influenza,
and 1 negative sample. Using our newly developed PCR
we correctly identified B. pertussis even in the lowest
concentration of 10 CFU/ml, and B. parapertussis.
B. holmesii and one IS481 containing B. bronchiseptica
were recognized correctly and not as B. pertussis. Hae-
mophilus influenza did not cross react with any of the
targeted IS elements.
Discussion
In this study we included IS1002 as target in PCR
based detection of Bordetella, in addition to IS481 and
IS1001, which is the commonly used PCR in The
Netherlands. We aimed to improve the specificity of
PCR because the addition of IS1002 enables the discri-
mination of B. pertussis, B. parapertussis, B. holmesii,
and B. bronchiseptica.
In the final report of QCMD (Pierard, D., O. Soetens,
and G. Ieven. Bordetella pertussis (BPDNA09) EQA
Pilot Study. February 2010. QCMD, Glasgow UK.), a
high degree of false positivity was observed for detection
of B. pertussis. It appeared that more than 80% of
laboratories contributing to the study used a PCR that is
based on IS481 and this accounts for the large propor-
tion of false positive results. Indeed, IS481 positive sam-
ples could either be positive for B. pertussis, B. holmesii,
or B. bronchiseptica. Here, we have shown that in our
PCR assay these organisms can be discriminated from
one another. There are however some limitations. In a
previous study [15] it was shown that IS481 is very
rarely found among B. bronchiseptica (1% of strains), in
contrast to IS1001 that was found in approximately 50%
of the studied strain collection. Consequently, approxi-
mately 50% of B. bronchiseptica carry no known IS ele-
ments and thus cannot be detected by IS-based PCR.
B. bronchiseptica s t r a i n st h a tc o n t a i nac o p yo fIS481
cannot be discriminated from B. holmesii using IS-based
PCRs. If PCR presents a single IS481 positive signal, one
might re-investigate the sample using the B. holmesii
specific PCR targeting the recA gene that was described
earlier [18] to discriminate from B. bronchiseptica.
The performance of our assay may fail if clinical sam-
ples might contain more than one Bordetella species.
However, after more than 15 years of experience with
PCR detection of B. pertussis (IS481) and B. parapertus-
sis (IS1001), we did not find more than one Bordetella
species present in clinical specimens.
During the evaluation, we sometimes observed a weak
positive signal for IS481 (Ct > 37) from B. hinzii,
although high concentrations of this organism were
negative in PCR. This may indicate that B. hinzii might
contain an IS481-like sequence that does not exactly
match our PCR. As B. hinzii is solely confined to birds,
this finding will not confound PCR based on IS481,
IS1001 and IS1002 for detection and discrimination of
the clinically relevant Bordetella species.
Conclusions
In conclusion, we have developed a real time PCR with
improved specificity for detection and discrimination of
all clinically relevant Bordetella species.
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